Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 100,741 | 132,641 | 129,631 | 148,489 | 141,077 |
| Cost of Goods | 66,541 | 84,299 | 70,744 | 90,618 | 76,926 |
| Gross Profit | 34,200 | 48,342 | 58,887 | 57,871 | 64,151 |
| Operating Expenses | 50,973 | 48,835 | 53,863 | 54,218 | 60,180 |
| Operating Income | -16,232 | -194 | 5,768 | 4,271 | 4,897 |
| Interest Expense | 41 | 50 | 45 | 283 | 25 |
| Other Income | 438 | 264 | 3,312 | 149,732 | 199 |
| Pre-tax Income | -15,835 | 20 | 9,035 | 153,720 | 5,071 |
| Income Tax | -6,213 | 200 | 3,416 | 48,278 | 272 |
| Net Income Continuous | -9,622 | -180 | 5,619 | 105,442 | 4,799 |
| Net Income | $-9,622 | $-180 | $5,619 | $105,442 | $4,799 |
| EPS Basic Total Ops | -0.16 | 0.00 | 0.08 | 1.59 | 0.07 |
| EPS Basic Continuous Ops | -0.15 | 0.00 | 0.08 | 1.59 | 0.07 |
| EPS Diluted Total Ops | -0.16 | 0.00 | 0.08 | 1.55 | 0.08 |
| EPS Diluted Continuous Ops | -0.15 | 0.00 | 0.08 | 1.55 | 0.07 |
| EBITDA(a) | $-10,708 | $6,109 | $17,550 | $16,668 | $68,452 |